Optimization Dose Study on Pharmacokinetics and Pharmacodynamics of Colistin in Critically Ill Patients

NCT02408185 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Critical Illness

Interventions

DRUG: Colistin 6 million units + 240mg/8h
DRUG: Colistin 6 million units + 360mg/12h

Sponsor

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla